BRAF Mutations Occur Infrequently in Ovarian Cancer but Suggest Responsiveness to BRAF and MEK Inhibition

Detalles Bibliográficos
Autores principales: Campos, Maira P., Cohen, Melissa, Von Euw, Erika, Velculescu, Victor, Kujak, Jennifer L., Conklin, Dylan, Hallberg, Dorothy, Slamon, Dennis J., Elvin, Julia, Konecny, Gottfried E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2018
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6886743/
https://www.ncbi.nlm.nih.gov/pubmed/31799491
http://dx.doi.org/10.1200/PO.18.00025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6886743/
https://www.ncbi.nlm.nih.gov/pubmed/31799491
http://dx.doi.org/10.1200/PO.18.00025

Ejemplares similares